ASCP Pathology Assistant Practice Exam

Session length

1 / 20

Which demographic is primarily affected by Myasthenia Gravis?

Men

Children

Women

Myasthenia Gravis is primarily a neuromuscular disorder that affects the communication between nerves and muscles, leading to varying degrees of weakness in skeletal muscles. Epidemiological studies show that this condition predominantly affects women, particularly those under the age of 40. The onset can occur at different life stages, but the significant gender disparity is notable, with women being more likely to develop Myasthenia Gravis compared to men.

This condition's association with women is thought to be influenced by hormonal factors, which may play a role in the disease's pathogenesis. While men can also develop the disease and there are instances of onset in the elderly, the peak development in women under 40 establishes their demographic as the primary group affected. Understanding these demographic trends is crucial for diagnostics, treatment planning, and patient education.

Elderly individuals

Next question

Find the option that is right for you!

All options are one-time payments.

$25.99

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
👑$59.99 $171.99 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $171.99 usd value for $59.99! You save $106!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$15.99 $24.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy